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ABSTRACT
We evaluate the effects of disease type and latency on willingness to pay (WTP) to reduce
environmental risks of chronic, degenerative disease. Using contingent-valuation data collected from
approximately 1,200 respondents in Taiwan, we find that WTP declines with latency between
exposure to environmental contaminants and manifestation of any resulting disease, at a 1.5 percent
annual rate for a 20 year latency period. WTP to reduce the risk of cancer is estimated to be about
one-third larger than WTP to reduce risk of a similar chronic, degenerative disease. The value of risk
reduction also depends on the affected organ, environmental pathway, or payment mechanism:
estimated WTP to reduce the risk of lung disease due to industrial air pollution is twice as large as
WTP to reduce the risk of liver disease due to contaminated drinking water.
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Many environmental regulations are directed toward reducing risks of cancer and 
other disease. Yet most of the empirical literature on valuing health risk relies on 
estimates of the compensating wage differentials that workers receive for bearing risks of 
fatal injury in the workplace (Viscusi, 1993). The applicability of these wage-differential 
estimates to changes in environmental health risks is uncertain. Environmentally-induced 
cancer and other diseases differ from occupational fatal injuries in several dimensions 
that may affect preferences. Two that may be of particular importance are (1) the latency 
period between exposure to the hazardous condition and the manifestation of adverse 
health effects, and (2) dread or other factors that lead to greater fear of cancer than of 
other causes of fatality (Revesz, 1999; Sunstein, 1997). In addition, reflecting the great 
public attention given to cancer, there may be differences in concern about cancer and 
other degenerative, fatal diseases that can be caused by exposure to environmental 
contaminants. 
We use contingent valuation (CV) to test for effects of disease type and latency 
on individual willingness to pay (WTP) to reduce risks of developing a fatal cancer or 
other chronic, degenerative disease through exposure to environmental pollution. 
Because the consequences of developing cancer are more similar to those of other fatal 
diseases than they are to acute trauma in a workplace or other accident, our estimates of 
the effect of disease type on WTP may understate any difference in WTP between cancer 
and trauma. Data were collected from 1,248 respondents in Taiwan. We find that WTP 
declines with the latency period between exposure to environmental contaminants and 
manifestation of any resulting disease, and that WTP depends on the affected organ, 
environmental pathway, or payment mechanism. Our results also suggest the existence of 
a cancer premium, although the effect is not quite statistically significant in our preferred 
model specification. 
In the following section, we provide an overview of the economic theory and 
previous empirical results concerning the effects of disease type and latency on 
willingness to pay for reductions in mortality risk. The CV survey instrument and sample 
population are described in Section 3. Section 4 describes the regression model used to 2 
 
describe the dependence of WTP on characteristics of the risk and of the respondent. 
Regression-model estimates suggest that WTP declines with the latency period between 
exposure to the environmental contaminant and manifestation of the disease, by about 
one-fourth over a 20 year latency period. WTP to reduce risk of cancer is estimated as 
about one-third larger than WTP to reduce the risk of an alternative degenerative and 
fatal disease. In addition, we find that WTP depends on the affected organ, environmental 
medium, or payment mechanism: estimated willingness to pay higher prices of consumer 
goods to reduce the risk of lung disease from air pollution is about twice as large as 
estimated willingness to pay higher water-utility rates to reduce the risk of liver disease 
from contaminated drinking water. Conclusions are in Section 5. 
2. Economic Theory of WTP to Reduce Mortality Risk 
The economic approach to valuing mortality risk was developed by Drèze (1962), 
Schelling (1968), and Jones-Lee (1974). The individual’s rate of tradeoff between wealth 
and risk in a specified time period (e.g., the current year) is characterized by his marginal 
rate of substitution between survival probability s and wealth or income w. The marginal 
rate of substitution 
ds
dw
−  (holding utility constant) is called the “value per statistical life” 
(VSL).  
VSL is not a universal constant but varies by individual and circumstance. The 
standard economic model of preferences for wealth and mortality risk (Drèze, 1962; 
Jones-Lee, 1974; Weinstein et al., 1980) assumes that an individual’s welfare can be 
represented as 
  EU(s, w) = s ua(w) + (1 – s) ud(w)      (1) 
where s is the individual’s chance of surviving the current period and ua(w) and ud(w) 
represent his indirect utility as a function of wealth conditional on surviving and not 
surviving the period, respectively. The function ud(• ) incorporates the individual’s 
preferences for bequests and can incorporate any financial consequences of dying (such 
as medical bills or life-insurance benefits). In this one-period model, wealth and income 
are treated as equivalent, but the difference between them can be important in multi-
period models. 3 
 
The individual’s VSL is derived by differentiating equation (1) holding expected 
utility constant to obtain 
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where prime indicates first derivative. The numerator in equation (2) is the difference in 
utility between surviving and dying in the current period. The denominator is the 
expected marginal utility of wealth, i.e., the utility associated with additional wealth 
conditional on surviving and dying in the period weighted by the probabilities of these 
events. Assuming that survival is preferred to death and that greater wealth is preferred to 
less, both numerator and denominator are positive and so VSL is positive. If the marginal 
utility of wealth is non-negative, and greater in the event of survival than death (i.e., 
ua'(w) > ud'(w) ≥  0), then VSL decreases in survival probability s. Weak risk aversion 
with respect to wealth, conditional on survival and on death (i.e., ua" ≤  0, ud" ≤  0), is a 
sufficient condition for VSL to increase with wealth. 
Accounting for Latency 
In equation (2), VSL is defined in terms of wealth and mortality risk in a single 
period. Many environmental health risks are characterized by a latency period between 
the time an individual is exposed to an agent and the time when he may die from its toxic 
effect. Since preventive measures must be undertaken before the exposure occurs, there is 
a need to determine WTP now to reduce the risk of fatality in a future period. We focus 
on WTP for a temporary risk reduction, i.e., one that reduces mortality risk in a single 
period. WTP to reduce mortality risk in multiple future periods (e.g., by permanently 
reducing exposure to an environmental toxicant) can be calculated by summing WTP to 
reduce risk in each of the future periods (Johannesson et al., 1997). 
Intuitively, one might expect that WTP to reduce a latent risk must be smaller 
than WTP to reduce a current risk by the same amount, since reducing a current risk 
increases the chance of surviving both current and future periods while reducing a future 
risk increases only the chance of surviving the future periods. This intuition is 
misleading. An earlier risk reduction does not necessarily stochastically dominate a later 
risk reduction, and so preferences between reducing current and latent risks will depend 4 
 
on the utility associated with different periods of life. WTP to reduce future mortality risk 
can be less than, equal to, or greater than WTP to reduce current risk by the same 
amount.  
Consider a multi-period model where the probabilities of surviving the first and 
second periods, conditional on being alive at the beginning of these periods, are s1 and s2, 
respectively. The probability of surviving at least one period is s1 and the probability of 
surviving at least two periods is s1 • s2. Reducing the first-period risk by an amount ∆  
increases these probabilities to (s1 + ∆)  and (s1 + ∆ ) s2, respectively. Reducing the 
second-period risk by ∆  does not affect the probability of surviving at least one period 
but increases the probability of surviving at least two periods to s1 (s2 + ∆ ). Comparing 
the probabilities of surviving at least one period, the first-period risk reduction is clearly 
preferred. In contrast, the probability of surviving at least two periods is larger for the 
second-period risk reduction than for the first-period risk reduction if s2 < s1. Hence the 
earlier risk reduction will stochastically dominate the later risk reduction only when s2 ≥  
s1.
1 
Since conditional mortality rates tend to rise with age, s2 is usually smaller than s1 
(for periods of equal duration). In this case, reducing current mortality risk does not 
stochastically dominate reducing future mortality risk by the same amount, and so WTP 
to reduce current and future risks will depend on the utility associated with surviving for 
different lengths of time. Typically, WTP to reduce a current risk will exceed WTP to 
reduce a latent risk. However, if the utility of short-term survival is small compared with 
the utility of longer-term survival, future risk reduction may be preferred to current risk 
reduction and WTP to reduce risk can increase with latency. For example, consider an 
individual suffering a painful illness in period 1 who will recover to full health at the end 
of period 2. If the illness is so painful that he would prefer to die rather than to live the 
rest of his life with the illness, the only benefit of surviving period 1 is that it increases 
his chance of surviving to the end of period 2, when he will recover. If s2 < s1, then 
                                                 
1 In the case of permanent risk reductions (i.e., those that increase the survival probability by ∆  in 
every period after the end of any latency period), an intervention with a shorter latency period 
increases the chance of surviving for every number of periods, is stochastically dominant, and 
will be associated with a larger WTP.  5 
 
increasing s2 will enhance his probability of surviving until he recovers by more than 
increasing s1, and so his WTP will be larger for the future than for the current risk 
reduction. 
Standard economic theory suggests that the appropriate procedure to account for 
latency is to value the risk change using the VSL representing the individual’s value 
when the harmful effects of the risk manifest, and to adjust for the time-value of money 
before then (Cropper and Sussman, 1990; Cropper and Portney, 1990; Johannesson et al., 
1997). Consider a simple two-period model in which the individual seeks to maximize 
his expected present value of utility 
  EU = s1 u1(c1) + s1 s2 u2(c2)       (3)   
subject to a budget constraint 
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In equation (3), s1 and s2 are the probabilities of surviving periods 1 and 2, conditional on 
being alive at the start of each period. The functions uj(cj), j = 1, 2, represent the utility in 
period j of consumption cj. They are assumed to be increasing and weakly concave (uj' > 
0, uj" ≤ 0). Any effects of age, duration of period, or preferences for current relative to 
future utility may be incorporated in the within-period utility functions. For simplicity, 
the marginal utility of a bequest is assumed to be zero.
2 
The first-order condition for optimizing consumption between periods is 
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As written, the budget constraint (4) implies the individual can save or borrow against 
lifetime wealth B at a constant consumption-discount rate r. The first-order condition (5) 
is necessary for optimization if the individual can save and borrow at least small amounts 
at rate r. The rate may depend on the individual’s survival probabilities. With perfect 
contingent-claim markets, the individual can transfer consumption between periods at a 
rate satisfying (1 + r) = (1 + ρ ) / s1, where ρ  is a risk-free interest rate and no payment is 
                                                 
2 Other life-cycle models (e.g., Shepard and Zeckhauser, 1984; Rosen, 1988; Ng, 1992) also 
assume a zero marginal utility of bequest, which avoids the question of how the utility of a 
bequest depends on when the individual dies. 6 
 
made in the second period if the individual dies in the first period.
3 For secured loans, the 
individual may borrow or save at the risk-free interest rate, which is independent of his 
mortality risk.  
The marginal rate of substitution between period j consumption and period k 
survival probability may be denoted VSLj,k. Differentiating equation (3), holding 
expected utility constant, implies that current WTP to reduce current mortality risk is 
given by  
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and future WTP to reduce future risk is given by  
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Current WTP to reduce future mortality risk is simply the present value of future 
WTP to reduce future risk. Combining equations (7) and (8), 
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where the second equality is obtained by substitution from the first-order condition (5). 
The effect of latency on WTP for risk reduction depends on how the rate of 
substitution between contemporaneous consumption and survival probability changes 
over time. If the rate of substitution increases sufficiently over time (i.e., if VSL2,2 > (1 + 
r) VSL1,1), then WTP to reduce a latent risk will exceed WTP for an equally large 
reduction in current risk. To determine the conditions under which latency increases 
WTP, subtract equation (7) from equation (6) to obtain 
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3 If the individual dies in the first period, his estate is not required to repay any loans and forfeits 
any savings. 7 
 
WTP to reduce a latent risk exceeds WTP to reduce a similar current risk (i.e., VSL1,2 > 
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If the two periods are of equal duration, the right-hand side of equation (11) is likely to 
be positive, since hazard rates typically increase with age. If so, and if first-period utility 
is sufficiently small relative to second-period utility, condition (11) may be satisfied. 
Such a result seems unlikely but cannot be ruled out without further restrictions on the 
utility functions.
4 
Note that current WTP to reduce a latent risk (equations (7) and (9)) does not 
incorporate any component related to anxiety about whether the latent risk will prove 
fatal. While such a component might be important in assessing WTP to avoid exposure to 
a specific hazard (such as the risk of getting smallpox from vaccination), it seems 
unlikely that the degree of anxiety about the potential harm from exposure to continuing 
environmental risks is sensitive to small changes in the magnitude of the risk that do not 
eliminate the risk entirely. 
Equation (9) shows that WTP to reduce a latent risk depends on the individual’s 
future WTP to reduce the future risk, i.e., his future VSL. The difference between an 
individual’s current and future VSL depends on two factors: he will be older, and the date 
will be later. Age affects VSL because the individual’s life expectancy, health, earnings, 
opportunities for spending on other goods, and other factors vary with stage of the life 
cycle. Time or date affect VSL through secular changes in productivity, the availability 
of medical and other technologies for investing in longevity, and other factors. A number 
of theoretical and empirical studies have examined the effects of age on VSL, but the 
effect of date has received little attention. Because of secular changes in productivity and 
other factors, the VSL at age 70 of a current 30 year old is unlikely to be equal to the 
current VSL of a current 70 year old.  
                                                 
4 If the within-period utility functions are identical, u1(•) = u2(•), then WTP to reduce mortality 
risk unambiguously declines with latency. 8 
 
The effect of age has been examined in theoretical models and, to a limited 
extent, by empirical studies. Theoretical models similar to equations (3) and (4) but 
including many periods (e.g., Shepard and Zeckhauser, 1984; Rosen, 1988; Ng, 1992) 
suggest that two factors influence the life-cycle pattern of VSL. First, the number of 
future life years at risk declines as one ages, so the benefit of surviving the current period 
(the numerator in equation (2)) declines. Second, the opportunity cost of spending on risk 
reduction (the denominator in equation (2)) also declines with age as savings accumulate, 
the investment horizon approaches, and the survival probability s decreases. The net 
effect of these changes may cause VSL to fall or rise with age (Ng, 1992; Hammitt, 
2000a). 
In models that assume an individual can borrow against future earnings, VSL 
typically declines with age (e.g., Rosen, 1988). Shepard and Zeckhauser (1984) calculate 
that VSL for a typical American worker falls by a factor of three from age 25 to age 75. 
If individuals can save but not borrow, VSL rises in early years as the individual’s 
savings (and earnings) increase before it ultimately declines. In this case, Shepard and 
Zeckhauser find that VSL peaks near age 40 and is less than half as large at ages 20 and 
65.  
Ng (1992) argues that the rate at which individuals discount their future utility is 
likely to be smaller than the rate of return to financial assets, whereas Shepard and 
Zeckhauser (1984) assume these rates are equal. If the utility-discount rate is smaller than 
the rate of return, individuals should save more when they are young and consume more 
when old. Under these conditions, VSL may not peak until age 60 or so (Ng, 1992). Even 
if individuals discount future utility at the rate of return, younger people who are prudent
5 
might be anticipated to save more, and spend less on reducing mortality risk, because of 
the greater range of future financial contingencies they face. 
Empirical evidence of the effect of age on VSL is mixed, with most results 
suggesting age has only a modest effect. Many studies that do not focus on the effect of 
age nevertheless include it as one of several covariates in a regression model explaining 
                                                 
5 An individual is prudent if financial risk increases his expected marginal utility of wealth, which 
requires that the third derivative of his utility function for wealth is positive (Kimball, 1990). 9 
 
WTP for risk reduction. The results of these studies are somewhat contradictory, with 
several finding VSL increases with age (e.g., Gerking et al., 1988; Lee et al., 1997) and 
others finding VSL decreases with age (e.g., Buzby et al., 1995; Hammitt and Graham, 
1999; Corso et al., 2001). Other studies find that VSL first rises then falls with age, 
peaking in middle age (Jones-Lee et al., 1985; Johannesson et al., 1997). 
Viscusi and co-authors find that VSL is proportional to the present value of future 
life years. The implied effect of life expectancy on VSL is sensitive to the estimated 
discount rate, which varies from about 1 to 17 percent per year. For rates of 10 percent 
and above (Moore and Viscusi, 1988, 1990b; Viscusi and Moore, 1989; Dreyfus and 
Viscusi, 1995), tripling future longevity from 20 to 60 years increases VSL by no more 
than 17 percent. For a 1 to 2 percent discount rate (Moore and Viscusi, 1990a, 1990b), 
the same change in longevity increases VSL by a factor of 2.0 to 2.5. 
Three recent empirical studies are specifically directed toward estimating the 
effect of age on VSL. Krupnick et al. (2002) conducted a CV study of WTP for a 
hypothetical intervention that would reduce the respondent’s risk of dying in the next 10 
years, restricting their sample to Canadian respondents aged 40 years and older. Krupnick 
et al. estimated that VSL is roughly constant for ages 40 – 69, and is about 30 percent 
smaller for individuals aged 70 and older. Using a similar survey instrument with 
American respondents, Alberini et al. (2002) found no statistically significant effect of 
age, although their point estimate suggests that VSL is about 20 percent smaller for 
respondents older than 70 than for younger respondents. Smith et al. (2001) estimated 
compensating-wage differential estimates using data from the Health and Retirement 
Survey. Their estimates of VSL for individuals aged 51 – 65 are not sensitive to age and 
are comparable to standard estimates for younger populations.  
The effect of calendar time on VSL has received relatively little attention in the 
literature, except to observe that if income grows over time, VSL might be expected to 
increase.
6 However, anticipated increases in income over the lifecycle may not affect 
VSL if WTP for current mortality-risk reduction is based on expected or “permanent” 
                                                 
6 In evaluating restrictions on CFCs to protect stratospheric ozone, for example, the US 
Environmental Protection Agency assumed that increases in income would cause VSL to grow at 
annual rates of 0.85 – 3.4 percent (EPA, 1987). 10 
 
income. In this case, anticipated secular earnings growth should be incorporated in 
current VSL. Changes in diet, medical technologies, environmental and other factors that 
influence the survival curve and the costs of increasing survival probabilities may also 
affect VSL, as they affect both the utility gain and the expected marginal cost of spending 
(the numerator and denominator of equation (2)). If VSL depends on current rather than 
permanent income, the effect changing income can be estimated using estimates of the 
economic growth rate and the income elasticity.  
Several studies have attempted to empirically estimate the effects of both calendar 
time and age on the benefits of public life-saving programs, by asking respondents to 
choose between hypothetical lifesaving programs that protect people of different ages or 
at different dates. These results do not necessarily reflect individual WTP to reduce 
different risks to oneself, since survey respondents are unlikely to compare programs 
solely in terms of their own private benefits. Horowitz and Carson (1990) estimated that 
respondents discount for calendar time at annual rates of 5 – 12 percent for delays of 
three to five years. Cropper et al. (1994) estimated a somewhat larger rate of 17 percent 
for five years, falling to 4 – 5 percent for delays of 50 – 100 years. Cropper et al. also 
asked respondents about programs to save people of different ages. Their results suggest 
that respondents prefer to protect people in young middle age. Lives of 30 year olds are 
valued about 11 times more highly than lives of 60 year olds. For comparison, lives of 20 
and 40 year olds are valued as equal to about eight and seven 60 year olds, respectively. 
These results are not sensitive to the age of the respondent. 
Subramanian and Cropper (2000) asked respondents to choose between different 
public programs to reduce health risks, and then asked how much more effective (in 
terms of lives saved) the less preferred program would need to be to make the respondent 
indifferent between programs. In each case, the risks concerned the same health endpoint 
but differed in delay until benefits would be achieved, voluntariness, controllability, and 
other factors. Using a multivariate regression to control for the effects of various factors, 
Subramanian and Cropper found that respondents discounted for delay. They estimated a 
marginal rate of substitution of –0.15, which implies that a 1.5 percent increase in the 
number of lives saved would compensate for a 10 percent increase in delay. 11 
 
To summarize, the effect of latency on WTP to reduce own mortality risk is 
uncertain. In theory, latency may increase or decrease WTP depending on whether 
individual VSL increases enough to offset the individual’s consumption discount rate. 
Empirical studies have not resolved this ambiguity. 
Magnitude of Cancer Premium 
The value of preventing a fatal cancer is often considered to be greater than the 
value of preventing a fatal trauma in a workplace or transportation accident (Revesz, 
1999; Sunstein, 1997). Cancer is also frequently viewed as more threatening than other 
degenerative conditions, such as heart disease (Jones-Lee et al., 1985). 
There are a number of differences between cancer and trauma fatalities that might 
affect relative WTP to reduce each risk, including the often protracted suffering from 
cancer before death and the knowledge with cancer that one’s condition will deteriorate 
and lead to death. It is not obvious that WTP to reduce cancer risk exceeds WTP to 
reduce accident risk, however, since dying of cancer and other degenerative diseases 
offers some benefits relative to dying in a fatal accident, such as the possibility of 
preparing for death by reconciling with family or putting financial affairs in order. 
Despite the plausibility that there may be a cancer premium, empirical support is limited. 
We are aware of no studies that compare individual WTP to reduce one’s own risk of 
cancer and other fatal disease, although several studies provide some information about 
the relative value of reducing risks of cancer and of fatal trauma. 
Jones-Lee et al. (1985) asked respondents to choose between public programs that 
would reduce the number of people dying in the next year by 100 from one of three 
causes (motor-vehicle crashes, heart disease, and cancer), and to indicate how much they 
would voluntarily contribute to reducing the number of deaths from the cause they 
selected. A large majority of respondents (76 percent) chose to reduce cancer deaths and 
the mean voluntary contribution was larger for cancer than for the other causes. If the 
mean contributions are interpreted as estimates of WTP to reduce own risk, the implied 
VSLs are £23 million for cancer, £13 million for heart disease, and £7 million for motor-
vehicle accidents. 12 
 
Mendeloff and Kaplan (1989) asked several sets of survey respondents to indicate 
the appropriate relative levels of public spending per life saved from various causes. 
Their sample of 38 non-elderly adults valued preventing cancer deaths due to workplace 
chemical exposures with a 30 year latency period as about twice as important as 
preventing trauma deaths due to workplace (construction) falls, and also valued 
preventing the cancer deaths as more valuable than preventing trauma deaths to younger 
people that could be prevented by improved road engineering (installation of median 
barriers and removal of roadside obstacles). Their sample of 190 college undergraduates 
reported a similar preference ordering, although the relative values differ less. In contrast, 
their samples of 18 retirees and of 35 undergraduates ranked the cancer deaths as similar 
to the construction and road-accident deaths. 
McDaniels et al. (1992) estimated WTP for programs to reduce a wide range of 
health risks using a CV study with 55 respondents. The programs were described as 
public goods that would reduce risks to the relevant populations, not only to the 
respondent. The authors also elicited risk-perception variables, such as dread. They found 
that WTP to reduce risk was positively associated with dread. 
Savage (1993) asked survey respondents to allocate a hypothetical $100 
contribution to research intended to reduce risks of stomach cancer, household fires, 
commercial-airplane accidents, and automobile accidents. He found that respondents 
would allocate the largest amount to stomach cancer ($47) with much smaller amounts 
($15 – $21) to the other risks. Although this study suggests greater WTP to reduce cancer 
risks, it does not measure individual WTP to reduce own risk. The value of research on 
methods to reduce risk of cancer (or the other fatality risks) depends on the probability 
that the research will identify interventions to reduce the risk, the magnitude of the risk 
reduction produced by the interventions, and the cost of implementing them. None of 
these parameters were specified, and so one cannot know what assumptions respondents 
made about them. In addition, the pattern of responses seems inconsistent with a 
measurement of WTP to reduce risk. Because the marginal efficacy of research spending 
is unlikely to decline significantly with a $100 increase, the optimal response is likely to 
be allocating all $100 to whichever risk the respondent believes will benefit most. 13 
 
Magat et al. (1996) used a risk-risk survey to elicit preferences for reductions in 
the risk of fatal automobile accidents and three chronic diseases: terminal lymph cancer, 
curable lymph cancer, and non-fatal nerve disease. The latency periods for the diseases 
were not specified in the survey instrument. The median respondent was indifferent 
between equal reductions in the probability of terminal lymph cancer and of fatal 
automobile accident, suggesting that there is no cancer premium or that any cancer 
premium is offset by an assumed difference in latency. The losses in utility due to curable 
lymph cancer and non-fatal nerve disease were estimated as 58 percent and 40 percent as 
large as the loss from a fatal automobile accident, respectively, which suggests that the 
utility loss associated with morbidity is 45 percent larger for lymph cancer than for nerve 
disease. 
3. Contingent Valuation Survey 
To estimate the effects of disease type and latency on WTP to reduce mortality 
risk, we conducted a contingent valuation (CV) survey. This section describes the survey 
instrument and sampling plan. 
Survey Instrument  
Respondents were questioned about their WTP to protect everyone in their 
household from each of four environmental health risks. The valuation questions are 
provided in the Appendix.  
The risks vary among respondents and differ with respect to whether the disease 
is latent or acute, cancer or non-cancer, and whether it affects the lung or the liver. To 
enhance credibility of the scenarios, the risks associated with liver disease are described 
as being produced by a contaminant in the water supply, and the risks associated with 
lung disease are attributed to industrial air pollution. The payment mechanism differs 
accordingly. In the liver case, respondents are asked about their willingness to pay higher 
water bills to cover the cost of additional treatment at the water utility. In the lung case, 
respondents are asked about their willingness to pay higher prices for consumer goods. 
Because the affected organ, environmental pathway, and payment mechanism are 
confounded in our design, we cannot distinguish their effects on WTP. In addition, 14 
 
because the interventions reduce risks to other community members in addition to those 
in the respondent’s household, estimated WTP may include some component of altruism.  
The risk reduction is described as an intervention to reduce current exposure to 
environmental contaminants. In the case of acute disease, respondents are told that if 
someone in their household develops the stated disease, symptoms will begin within a 
few months and they will live only about two to three years longer. In the latent case, 
they are told the person will not know if he or she was sufficiently exposed to develop 
the disease until symptoms begin about 20 years in the future. After developing 
symptoms, the prognosis is identical to the acute case. The symptom description is terse 
but includes what are believed to be the most salient aspects of the diseases. The 
description is identical for all four diseases (cancer/non-cancer, liver/lung). 
The magnitude of the risk reduction is also varied (either 2 per 100,000 or 8 per 
100,000 per year). Under conventional economic theory, WTP for a small reduction in 
mortality risk is nearly linear in the magnitude of the risk reduction. The sensitivity of 
estimated WTP to magnitude of risk reduction can be used as a diagnostic test of the 
performance of the survey instrument (Hammitt and Graham, 1999; Hammitt, 2000b; 
Corso et al., 2001). 
A split-sample design is employed in which respondents are randomly assigned to 
one of eight groups. All respondents are presented with four WTP questions, with the 
specific risk reductions varied among the sub-samples as detailed in Table A-1 (in the 
Appendix). 
WTP is elicited using double-bounded binary-choice questions. Each respondent 
is randomly assigned to one of five initial bid values (NT$50, 100, 200, 300, and 500).
7 
These amounts represent additional monthly expenditures. The values are based on 
responses to open-ended questions in two survey pretests. There is one follow-up 
question, where the bid is equal to twice the initial bid if the respondent indicates he 
would be willing to pay the initial amount, and equal to half the initial bid otherwise. 
Each respondent receives the same initial bid for the first two questions (which pertain to 
a common organ/environmental pathway) and a different initial bid for the second two 
                                                 
7 The exchange rate was 34.5 NT$ per US$ in May 2001. 15 
 
questions (which pertain to the other organ/environmental pathway). Discrete-choice 
questions are often preferred to open-ended questions because they appear to be easier 
for respondents to answer. The referendum format is incentive-compatible and was 
recommended by the NOAA panel (Arrow et al., 1993). The double-bounded formulation 
is more efficient than a single-bounded dichotomous-choice formulation (Hanemann et 
al., 1991). 
Survey Sample 
The survey was conducted in May 2001 using random-digit-dial computer-
assisted telephone interviewing in Taiwan. The sample was restricted to individuals aged 
16 years and older with earned income and residing in Taipei city or county, Taoyuan 
county, or Kaohsiung city or county. In total, 1,248 interviews were completed. The 
regions were chosen to include areas with relatively severe (Taoyuan, Kaohsiung) and 
relatively mild (Taipei) levels of industrial pollution. 
Table 1 reports the definitions of all variables together with the sample means and 
standard deviations. The sample statistics are consistent with expectations, given the 
sampling plan. The respondents’ mean age is 39 years, with a range of 16 to 70. Three-
quarters of the respondents are married and 55 percent are male. Almost one-quarter have 
obtained a college degree. The mean income is about US$14,000 per year. About 60 
percent describe their health as excellent or very good (alternative choices are good, fair, 
and poor). More than one-quarter of the respondents are current smokers, and about one-
sixth report they suffer from respiratory illness. About two-thirds routinely use seatbelts 
when traveling in an automobile. 
4. Results 
WTP is modeled as a function of health-risk attributes, the respondent’s socio-
economic characteristics, and variables characterizing risk attitudes. Regression models 
are estimated using the maximum-likelihood method under the assumption that WTP is 
lognormally distributed.
8 We include in the sample only the response to one randomly 
                                                 
8 Using a χ
2 test we find that the lognormal model provides a better fit than the Weibull, exponential, and 
log-logistic models. The estimated coefficients using alternative distributions have the same signs. We also 16 
 
selected question per respondent, so the observations are independent. This section 
reports estimates of how WTP to reduce health risks depends on the characteristics of 
those risks as well as on respondents’ personal characteristics.  
Effects of Health-Risk Characteristics on WTP 
To determine how WTP depends on the characteristics of the health risks, we 
estimate a regression that includes only dummy variables for the various risk 
characteristics: cancer/non-cancer, latent/acute, liver/lung, and magnitude of risk 
reduction. The results are shown in column 1 of Table 2. 
The estimated coefficient of the cancer variable is positive and almost significant 
(the p-value is 0.12). The point estimate suggests that WTP to reduce the risk of cancer is 
one-third larger than WTP to reduce the risk of an alternative disease. The coefficients of 
the latent and liver variables are both negative and statistically significant at the 10 
percent and 1 percent levels, respectively. WTP to reduce the latent risk is estimated as 
about one-fourth smaller then WTP to reduce the acute risk, which implies respondents 
discount for latency at about 1.5 percent per year. WTP to reduce the risk of liver disease 
from water pollution is estimated to be only half as large as WTP to reduce the risk of 
lung disease from air pollution.
9 
The estimated coefficient on risk magnitude allows us to reject the hypothesis that 
WTP is insensitive to the magnitude of risk reduction, but the magnitude of the 
coefficient is much smaller than the value (log(4) ≈ 1.4) required for estimated WTP to be 
proportional to magnitude of risk reduction. This result—that WTP is sensitive to risk 
magnitude, but less than proportionate—is consistent with nearly all previous CV studies 
of health-risk reduction (Hammitt and Graham, 1999; Krupnick et al., 2002) and may 
                                                                                                                                                 
evaluate the Weibull and lognormal results using a likelihood-ratio test. We can reject the Weibull 
distribution in favor of an alternative generalized Gamma distribution, but cannot reject the lognormal 
distribution against the alternative generalized Gamma distribution. As sensitivity analysis, we describe the 
Weibull results below.  
9 The Weibull model yields qualitatively similar results, although the p-values differ. The coefficient on 
cancer is significant at the 1 percent level and implies WTP to reduce cancer risk is 57 percent larger than 
WTP to reduce risk of a similar non-cancer disease. The coefficient on latency has a p-value of 0.11 and 
the point estimate suggests WTP to reduce the latent risk is 20 percent smaller than WTP to reduce the 
acute risk. WTP to reduce the risk of liver disease is highly significant and estimated as about half as large 
as WTP to reduce the risk of lung disease. 17 
 
reflect inadequate communication of the quantitative risk reduction to survey respondents 
(Corso et al., 2001).  
To control for question-order effects, we add three question-dummy variables (Q1 
– Q3) to the variables describing the risk characteristics. As shown in column 2 of Table 
2, estimated WTP seems to decrease with question order, although only the responses to 
the first and fourth questions differ significantly. This pattern suggests that respondents 
act as if they mentally allocate spending in response to each question and are less willing 
to spend on the later questions. Payne et al. (2000) found a similar effect in their study, 
where CV estimates of WTP for the first of five environmental goods was significantly 
larger than estimates of WTP for the remaining goods. Despite the statistically significant 
effect of question order, controlling for this factor has a negligible effect on the estimated 
coefficients of the risk characteristics.
10 
In order to identify any differences in the estimated cancer premium or latency 
effect with disease type or affected organ we added interaction variables to the 
specification reported in column 2. Interactions between Cancer and Latent, Cancer and 
Liver, and Latent and Liver, were entered individually and jointly. None of the 
coefficients on these interaction terms were significantly different from zero and their 
inclusion had little effect on the magnitude of the other coefficients. (Estimates of these 
specifications are omitted from the table.)  
Effects of Respondent Characteristics on WTP 
In column 3 of Table 2, we add respondent characteristics to the risk-
characteristic and question-order variables. We omit 94 observations for which personal 
characteristics are missing, so the sample size falls from 1,222 to 1,128 respondents.  
Addition of the respondent characteristics has a minimal effect on the estimated 
coefficients of the risk-characteristic variables. The cancer coefficient remains close to 
significant (the p-value is 0.103) and the cancer premium is estimated as 38 percent. The 
coefficient on latency is significant at the 10 percent level and implies WTP is one-fourth 
                                                 
10 The question-order variables also have little effect on the Weibull model. The coefficients and p-values 
for the cancer and liver variables are nearly identical to those reported in the previous note and the 
coefficient on latency has a p-value of 0.04. 18 
 
smaller for the latent than for the acute risk. The estimated value of reducing the risk of 
liver disease due to water contamination remains 50 percent smaller than WTP to reduce 
the risk of lung disease due to air pollution.
11 
Estimated WTP is significantly associated with some of the respondents’ socio-
economic characteristics. The estimated income elasticity (0.61, standard error = 0.20) is 
comparable to estimates obtained in other studies of health risk (e.g., Jones-Lee et al., 
1985; Mitchell and Carson, 1986; Liu et al., 1997; Corso et al., 2001; Mrozek and Taylor, 
2002; Viscusi and Aldy, 2002). Estimated WTP declines with age at a rate of about 2.3 
percent per year, and college-educated respondents are estimated to value risk reduction 
about 40 percent more than respondents with less education (the coefficient on college is 
almost significant, with a p-value of 0.106). In contrast, WTP is not significantly 
associated with the number of household members, even though the questions ask about 
WTP to reduce risk to everyone in the household. There is no significant association 
between WTP and either sex or marital status.  
Several variables are included as indicators of risk attitudes, but none are 
statistically significant. The negative coefficient for current smokers is consistent with 
wage-differential studies which suggest that smokers value safety less than non-smokers 
(Hersch and Viscusi, 1990; Hersch and Pickton, 1995; Viscusi and Hersch, 2001). WTP 
is not significantly associated with use of automobile seatbelts, perceived health status, 
presence of respiratory disease, or with perceived air and drinking-water quality (after 
controlling for geographic region). Moreover, we find no significant differences in WTP 
associated with ethnicity or geographic region of residence. 
Effect of Latency 
The estimated coefficients on latency suggest that respondents discount for 
latency at about 1.5 percent per year.
12 To evaluate this estimate, we examine its 
                                                 
11 For the Weibull model, the cancer premium is significant at the 1 percent level and estimated as 68 
percent. WTP for the latent risk is estimated to be one-fourth smaller than WTP for the acute risk and the 
p-value is 0.08. The estimated WTP to reduce liver disease remains about half as large as WTP to reduce 
lung disease and highly significant. 
12 The CV studies reported by Alberini et al. (2002) and Krupnick et al. (2002) included questions about 
the respondents’ WTP to reduce the risk of dying in the next decade and also in the decade following the 
respondent’s 70th birthday. Comparing these values suggests that respondents discount for latency at 19 
 
consistency with the theoretical result that WTP to reduce a future mortality risk depends 
on the individual’s consumption discount rate (which may depend on his survival 
probability) and the change in VSL between the current and future times (equation (9)). 
The change in VSL depends on differences in age, health, and other factors between the 
current and future periods. It may also depend on changes in income, to the extent these 
are not incorporated in current VSL.  




















       ( 1 2 )  
where WTP0 and WTPt are the individual’s current WTP to reduce mortality risk by a 
small amount ∆  at the current time and t years in the future, respectively, r is his 
consumption discount rate (as in equation (4)), at is a factor describing how VSL depends 
on age, g is the annual income-growth rate, and η  is the income elasticity.
13 From column 
(3) of Table 3, WTP20/WTP0 is estimated as 0.74 and a20 is estimated as 0.63 = e
-0.023 •  20. 
Since the estimated age effect reduces WTP by more than the observed discounting for 
latency, equation (12) implies that VSL is anticipated to increase because of increasing 
income (or other factors), or that the consumption discount rate is less than zero (equal to 
about -0.7 percent per year). Attributing the difference to anticipated income growth and 
using the estimated income elasticity of 0.61, the following pairs of consumption 
discount rate and anticipated income-growth rate are consistent with our results: (r = 0, g 
= 0.01), (r = 0.03, g = 0.06), (r = 0.05, g = 0.10), and (r = 0.10, g = 0.18). For the smaller 
discount rates, the anticipated income-growth rates appear reasonable. Taiwan has 
experienced rapid economic growth in recent years, with real rates of 5 and 6 percent per 
year and individual incomes typically rise with age. In contrast, the anticipated growth 
rates that are associated with the larger consumption discount rates seem implausible, 
potentially reflecting inadequate sensitivity of estimated WTP to latency.
  
                                                                                                                                                 
annual rates of 4.5 and 8 percent in the US and Canada, respectively (Maureen Cropper, personal 
communication, July 31, 2002). 
13 Moore and Viscusi (1990) present a similar equation. 20 
 
Value per Statistical Life 
Table 3 reports estimates of VSL as a function of disease type, latency, and 
organ/environmental pathway/payment mechanism. These are calculated using the 
corresponding estimates of WTP from the regression models in Table 2 to predict median 
WTP at the sample mean of the covariates for each risk reduction, dividing by the risk 
reduction and average household size (4.3), then averaging over the small and large risk 
reductions.  
Estimated VSL ranges between US$0.5 million and US$2.2 million. These values 
are substantially smaller than estimates for the US (Viscusi, 1993; Mrozek and Taylor, 
2002; Viscusi and Aldy, 2002) and are comparable to previous estimates for Taiwan. 
Using compensating wage differentials, Liu et al. (1997) estimated a value of 
approximately US$0.5 million using actuarial risk estimates for 1982 – 1986, and Liu and 
Hammitt (1999) estimated VSL in 1995 as US$0.6 million (controlling for injury risk) 
and US$1.2 million (not controlling for injury risk), using workers’ subjective risk 
estimates. Using CV, Fu et al. (1999) estimated WTP per statistical case of cancer 
avoided by reducing pesticide residues on food in Taiwan as US$0.6 – 1.3 million in 
1995.  
5. Conclusion 
Health benefits of environmental regulations are frequently associated with 
reduced risks of cancer and of other degenerative and fatal diseases. To date, there is 
little evidence regarding the extent to which individual WTP to reduce fatal risks differs 
by characteristics of the risk, including the type of disease or trauma and the latency 
period between exposure to the hazard and fatal outcome. 
In a general-population contingent-valuation study in Taiwan, we find that WTP 
to reduce risks of fatal cancer due to environmental pollution is larger than WTP to 
reduce risks of an otherwise similar degenerative disease, and that current WTP declines 
with the latency period between exposure to environmental contaminants and 
manifestation of disease. Respondents appear to discount at a rate of about 1.5 percent 
per year for a 20 year latency period. We also find that WTP to reduce risks of lung 
disease due to industrial air pollution through higher prices of consumer goods is 21 
 
substantially greater than WTP to reduce risks of liver disease due to water pollution 
through higher water-utility rates. Because these factors are confounded in our study 
design, we are unable to separately estimate the effects of differences in the affected 
organ (lung or liver), environmental pathway (air or drinking and bathing water), and 
payment mechanism (higher payments for consumer goods or higher water utility bills).  
We conjecture that the estimated differences in WTP between diseases (e.g., the 
cancer premium and the affected organ) may be sensitive to the comprehensiveness of the 
information about disease symptoms and prognosis provided to survey respondents. Even 
though we use identical language to describe the symptoms and prognosis of the four 
diseases, the descriptions are brief and respondents may have believed that cancers have 
more severe effects on health than the other diseases, or that lung disease has more severe 
effects than liver disease. In future work, we intend to assess the sensitivity of the 
estimated differences in WTP to the level of detail with which disease symptoms are 
presented to respondents. We anticipate that the estimated differences will be smaller 
when more information about the disease characteristics is provided to respondents. 
For evaluating environmental regulations, our results suggest that benefits of 
mortality-risk reduction should be reduced modestly to account for the latency period 
between exposure and manifestation of disease. They further suggest the existence of 
substantial differences in VSL associated with specific diseases. In particular, reductions 
in the risk of fatal cancer may be more valuable than comparable reductions in risks of 
other fatal, degenerative disease. Values of risk reduction may also be sensitive to the 
affected organ and environmental pathway. These results require confirmation and 
further refinement for use in policy analysis. 22 
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Table 1. Variable names, definitions, and descriptive statistics 
Variable Definition  Mean  (Std.  Dev.)
Cancer  1 if the question is about cancer, 0 otherwise  0.504  (0.500) 
Liver  1 if liver disease, 0 if lung disease  0.500  (0.500) 
Latent  1 if disease is latent, 0 otherwise  0.530  (0.499) 
Risk magnitude  1 if initial risk is high (8/100,000), 0 if low (2/100,000)  0.497  (0.500) 
Q1  1 if first question, 0 otherwise  0.250  (0.433) 
Q2  1 if second question, 0 otherwise  0.250  (0.433) 
Q3  1 if third question, 0 otherwise  0.250  (0.433) 
Household size  Number of people in household  4.287  (1.758) 
Age  Respondent’s age  in years  39.09  (10.11) 
Male  1 if respondent is male,  0 if female  0.555  (0.497) 
Married  1 if the respondent is married, 0 otherwise  0.748  (0.434) 
Ln(income)  Log of monthly income (NT$, 1US$= 34.5NT$)  10.62  (0.509) 
College  1 if the respondent has college degree, 0 otherwise  0.238  (0.426) 
Health  1 if perceived health is excellent or very good, 0 otherwise  0.593  (0.491) 
Disease  1 if respondent has  respiratory disease, 0 otherwise  0.163  (0.369) 
Smoker  1 if respondent is currently a smoker, 0 otherwise  0.268  (0.443) 
Seat belt  1 if respondent regularly uses seat belt, 0 otherwise  0.647  (0.478) 
Air quality  Perceived air quality, from 0 (worst) to 10 (best)  5.738  (2.130) 
Water quality  Perceived drinking water quality, from 0 (worst) to 10 
(best) 
5.935 (2.034) 
Taiwanese  1 if ethnicicy is Taiwanese, 0 if Chinese  0.834  (0.372) 
Taipei city  1 if respondent lives in Taipei city, 0 otherwise  0.276  (0.447) 
Taipei county  1 if respondent lives in Taipei county, 0 otherwise  0.321  (0.467) 
Taoyuan county  1 if respondent lives in Taoyuan county, 0 otherwise  0.168  (0.373) 




Table 2. Regression results 
Variable  (1) (2) (3) 
Constant 6.298***  6.064***  0.032 
  (0.170) (0.209) (2.090) 
Cancer  0.304 0.305 0.324 
  (0.193) (0.194) (0.199) 
Liver  -0.749*** -0.737*** -0.733*** 
  (0.194) (0.195) (0.201) 
Latent  -0.273* -0.373** -0.302* 
  (0.163) (0.175) (0.181) 
Risk  magnitude  0.510** 0.524** 0.519** 
  (0.163) (0.162) (0.168) 
Q1   0.506**  0.500** 
   (0.239)  (0.249) 
Q2   0.317  0.300 
   (0.224)  (0.232) 
Q3   0.281  0.318 
   (0.227)  (0.235) 
Household size      0.024 
     (0.049) 
Age     -0.023** 
     (0.011) 
Male     -0.163 
     (0.194) 
Married     -0.175 
     (0.240) 
Ln(income)     0.611** 
     (0.199) 
College     0.345 
     (0.213) 
Health     0.057 
     (0.173) 
Disease     -0.138 
     (0.229) 
Smoker     -0.214 
     (0.211) 
Seatbelt     0.010 
     (0.189) 
Air quality      0.066 
     (0.042) 
Water quality      0.000 
     (0.042) 
Taiwanese     0.173 
     (0.219) 28 
 
Taipei city      -0.323 
     (0.340) 
Taipei county      -0.172 
     (0.321) 
Taoyuan county      0.175 
     (0.356) 
Kaohsiung city      0.388 
     (0.357) 
Sigma  2.413 2.404 2.361 
  (0.093) (0.093) (0.095) 
Sample  size  1,222 1,222 1,128 
Log  likelihood  -1485.36 -1482.98 -1361.11 
Note: Standard errors are in parentheses. ***, **, and * represent 




Table 3. Estimated value per statistical life (million US$) 
Disease  type  Latency  Organ/pathway  (1) (2) (3) 
Cancer  Latent  Lung  1.6 1.5 1.6 
Cancer  Acute  Lung  2.1 2.2 2.1 
Non-cancer  Latent  Lung  1.2 1.1 1.1 
Non-cancer  Acute  Lung  1.6 1.6 1.5 
Cancer  Latent  Liver  0.8 0.7 0.7 
Cancer  Acute  Liver  1.0 1.1 1.0 
Non-cancer  Latent  Liver  0.6 0.5 0.5 
Non-cancer  Acute  Liver  0.7 0.8 0.7 
Note: Estimates correspond to models in corresponding column of Table 2. 
VSL calculated as the average of the values for the two risk-reduction magnitudes. 
 29 
 
Appendix: Survey Questions 
1. Liver disease / water pathway 
As you know, the drinking water that is piped to your home is treated to remove 
microbial and chemical contaminants. However, there is always a risk that some 
contaminants may be present in the water.  
 
Consider what you would do if you learned that there is a contaminant in the water 
supplied to your home that may cause [liver cancer / liver failure]. You and other people 
in your household can be exposed to the contaminant by drinking the water, and also by 
using it for bathing. The chance that you or someone in your household will be exposed 
to enough of this contaminant to cause [liver cancer / liver failure] is [2 / 8] chances in 
100,000 per year.  
 
Insert [Acute] or [Latent] description: 
 
[Acute] The type of [liver cancer / liver failure] caused by this contaminant is always 
fatal. If someone in your household is exposed to enough of the contaminant to develop 
[liver cancer / liver failure], they will develop symptoms within a few months, and will 
live only about 2 to 3 years longer.  
 
[Latent] The type of [liver cancer / liver failure] caused by this contaminant is always 
fatal, but it takes a long time to develop. If someone in your household is exposed to 
enough of the contaminant to develop [liver cancer / liver failure], they will not know it 
until they begin to experience symptoms about 20 years later. After developing these 
symptoms, they will live only about 2 to 3 years longer. 
 
If someone in your household develops [liver cancer / liver failure], the symptoms will be 
mild at first. Eventually, they will become so weak that they will have to stay in bed or a 
wheel chair most of the time. They will not be able to take care of themselves. Once this 
occurs, they will die within one to two months. 
 
The water-treatment plant can install additional treatment equipment to reduce the chance 
that the contaminant will be in your water. The treatment equipment is expensive, and the 
people who manage the plant are not sure if it is worth the cost. If the treatment 
equipment is installed, it will reduce the chance that someone in your household will be 
exposed to enough of the contaminant to develop [liver cancer / liver failure] from [2 / 8] 
chances in 100,000 per year to almost zero—to only 1 chance in 10 million per year.  
 
If the plant installs the equipment, it will need to recover the cost by increasing the 
amount that consumers pay for their water. If the additional cost to your household would 
be NT$ [50, 100, 200, 300, 500] per month, would you want the plant to install the 
treatment equipment to reduce the chance that you or someone else in your household 
would develop [liver cancer / liver failure]?  30 
 
 
2. Lung disease / air pathway 
Air pollution that is released from factories may cause [lung cancer / bronchitis]. 
Consider what you would do if you learned that the chance that someone in your 
household will be exposed to enough of this pollution to cause [lung cancer / bronchitis] 
is [2 / 8] chances in 100,000 per year. 
 
Insert [Acute] or [Latent] description: 
 
[Acute] The type of [lung cancer / bronchitis] caused by this pollution is always fatal. If 
someone in your household is exposed to enough of the pollution to develop [lung cancer 
/ bronchitis], they will develop symptoms within a few months, and will live only about 2 
to 3 years longer. 
 
[Latent] The type of [lung cancer / bronchitis] caused by this pollution is always fatal, but 
it takes a long time to develop. If someone in your household is exposed to enough of the 
pollution to develop [lung cancer / bronchitis], they will not know it until they begin to 
experience symptoms about 20 years later. After developing these symptoms, they will 
live only about 2 to 3 years longer. 
 
If someone in your household develops [lung cancer / bronchitis], the symptoms will be 
mild at first. Eventually, they will become so weak that they will have to stay in bed or a 
wheel chair most of the time. They will not be able to take care of themselves. Once this 
occurs, they will die within one to two months. 
 
The government can require factories to install additional air-pollution-control equipment 
to reduce the amount pollution coming out of the factory. The equipment will reduce the 
chance that someone in your household will be exposed to enough of the pollution to 
develop [lung cancer / bronchitis] from [2 / 8] chances in 100,000 per year to almost 
zero—to only 1 chance in 10 million per year.  
 
If the government requires the factories to install this pollution-control equipment, it will 
increase the cost of many of the goods you buy. This would increase your cost of living. 
If the additional cost to your household would be NT$ [50, 100, 200, 300, 500] per 
month, would you want the factories to install the pollution-control equipment to reduce 





Table A-1. Survey design 
Sub-sample A1  A2 
Question 1  low risk, latent, liver cancer   high risk, acute, liver cancer 
Question 2  low risk, acute, liver cancer   high risk, latent, liver cancer 
Question 3  low risk, latent, bronchitis   high risk, latent, bronchitis 
Question 4  low risk, acute, bronchitis   high risk, acute, bronchitis 
Sub-sample A3  A4 
Question 1  low risk, latent, liver failure   high risk, latent, liver failure 
Question 2  low risk, acute, liver failure   high risk, acute, liver failure 
Question 3  low risk, acute, bronchitis   high risk, latent, bronchitis 
Question 4  low risk, latent, bronchitis   high risk, acute, bronchitis 
Sub-sample B1  B2 
Question 1  low risk, latent, lung cancer   high risk, acute, lung cancer 
Question 2  low risk, acute, lung cancer   high risk, latent, lung cancer 
Question 3  low risk, acute, liver cancer   high risk, latent, liver cancer 
Question 4  low risk, latent, liver cancer   high risk, acute, liver cancer 
Sub-sample B3  B4 
Question 1  low risk, latent, bronchitis   high risk, latent, bronchitis 
Question 2  low risk, acute, bronchitis   high risk, acute, bronchitis 
Question 3  low risk, acute, liver cancer   high risk, latent, liver cancer 
Question 4  low risk, latent, liver cancer   high risk, acute, liver cancer 
Note: Describes the risk characteristics of the four questions asked to each of eight 
sub-samples of respondents. 
 
 